TOG Review (RCOG Journal)

MRCOG Part 2

Postpartum Problems (Neonatal)

Newborn screening and the role of genomic testing

Key Statistics

  • 9 — Conditions in UK newborn blood spot
  • 6,000–8,000 — Estimated rare diseases
  • 100,000 — Newborns – Generation study target

Don't-miss facts

  1. UK Blood Spot = 9 conditions (CHT, CF, SCD, 6 IMDs); 6 IMDs can only be declined as a group

  2. PPV varies 50–90% by condition; overall >99% of ~785,000 babies screened (2017–18) were "screen negative"

  3. gNBS challenge = interpreting pathogenicity/penetrance/expressivity without a phenotype in an asymptomatic newborn

  4. ICoNS criteria: include only if treatable/surveillance can start before age 5; never report VUS or carrier status

  5. Generation Study: 100,000 newborns, 208 conditions, WGS of cord blood, 2024–2027, ~40 NHS trusts

  6. Only pathogenic/likely pathogenic (ACGS) variants reported in GS; ~1% get a "condition-suspected" result

  7. GS data pseudonymised in NGRL; never shared with insurers/marketers; retained to age 16 then re-consent sought

  8. SMA = key example: early/pre-symptomatic gene therapy (replacing SMN1) transforms prognosis vs late treatment

Screening spectrum at a glance

UK Blood Spot: 9 conditions (TMS/other biomarkers) Generation Study: 208 conditions via WGS of cord blood

Abbreviation Key

  • gNBS — genomic newborn sequencing
  • MSUD — maple syrup urine disease
  • WGS — whole-genome sequencing
  • IVA — isovaleric acidaemia
  • NGS — next-generation sequencing
  • GA1 — glutaric aciduria type 1
  • TMS — tandem mass spectrometry
  • HCU — homocystinuria (pyridoxine unresponsive)
  • PKU — phenylketonuria UK
  • NSC — UK National Screening Committee
  • CF — cystic fibrosis
  • VUS — variant of uncertain significance
  • SMA — spinal muscular atrophy
  • ICoNS — Intl Consortium for Newborn Sequencing
  • SCID — severe combined immunodeficiency disease
  • ACGS — Association for Clinical Genomic Science
  • SCD — sickle cell disease
  • GS — the Generation Study
  • CHT — congenital hypothyroidism
  • NGRL — Natl Genomic Research Library
  • IMD — inherited metabolic disease
  • PPV — positive predictive value
  • MCADD — medium-chain acyl-CoA dehydrogenase def.

Source: To M, Etheredge H, Pichini A et al. Newborn screening and the role of genomic testing: what obstetricians need to know. The Obstetrician & Gynaecologist 2025;27:278–285. doi:10.1111/tog.70009

MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).

Included with a Pass Package

  • Audio overview of this guideline
  • Practice questions drawn from it
  • AI tutor answers grounded in its text
  • Your own annotations
Start free